Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Therapy areas
Orphan-paediatric
Orphan-paediatric
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Orphan-paediatric
Novel Scoring System Differentiates Viral From Bacterial Pneumonia in Hospitalised Children: Presented at ESPID – FirstWord Pharma
Firstwordpharma News
-
October 31, 2020
Orphan-paediatric
ERYTECH to Host Third Quarter 2020 Conference Call and Business Update on November 6, 2020 Nasdaq:ERYP
Orphan-paediatric
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Orphan-paediatric
Kezar Life Sciences Announces Orphan Drug Designations for KZR-616 for the Treatment of Polymyositis and Dermatomyositis
Orphan-paediatric
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting Nasdaq:ALBO
Orphan-paediatric
Idorsia establishes US commercial operations and leadership team Swiss Stock Exchange:IDIA
Globenewswire News
-
July 16, 2020
0
Orphan-paediatric
GSK licenses stable cell line technology to Orchard – FirstWord Pharma
Firstwordpharma News
-
July 16, 2020
0
Orphan-paediatric
Aquestive Therapeutics to Announce Second Quarter Financial Results and Recent Business...
Globenewswire News
-
July 15, 2020
0
Orphan-paediatric
FDA Approves Expanded BOTOX (onabotulinumtoxinA) Label for the Treatment of Pediatric...
Firstwordpharma News
-
July 12, 2020
0
Orphan-paediatric
Atox Bio’s Reltecimod Shows Effectiveness in Flesh-Eating Bacterial Infections
Biospace News
-
July 10, 2020
0
1
2
3
...
18
Page 1 of 18
- Advertisement -
MOST POPULAR
AmorChem invests in a new gene therapy approach to help patients...
February 24, 2020
Evotec Se Reports First Quarter 2019 Results and Provides Corporate Update
May 14, 2019
Homology Medicines Announces Peer-Reviewed Publication Demonstrating its AAVHSC Vectors Crossed the...
November 26, 2019
Catalyst Pharma Fires Back at Sen. Bernie Sanders’ Allegations
February 22, 2019
Load more
HOT NEWS
Deals
Vaccibody announces collaboration to study VB10.16 and atezolizumab (Tecentriq) in advanced...
Commercial
Cytovance Biologics Announces an Investment in Mass Spectrometry Services
Others
BioSpace Movers and Shakers: March 29
Clinical
Discovery of new step in how brain cells work could lead...
